LP
DXCM icon

LMR Partners’s DexCom DXCM Stock Holding History

LMR Partners’s Portfolio DXCM Stock Details DXCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$218K Sell
3,232
-305,854
-99% -$20.4M ﹤0.01% 1312
2026
Q1 		$19.4M Buy
+309,086
New +$21.5M 0.04% 223
2025
Q1 		– Sell
-153,324
Closed -$11.9M – 1440
2024
Q4 		$11.9M Buy
+153,324
New +$11.4M 0.1% 206
2024
Q2 		– Sell
-54,640
Closed -$7.58M – 1150
2024
Q1 		$7.58M Buy
54,640
+46,812
+598% +$5.88M 0.08% 230
2023
Q4 		$971K Sell
7,828
-7,000
-47% -$715K 0.01% 584
2023
Q3 		$1.38M Buy
+14,828
New +$1.67M 0.02% 441
2023
Q2 		– Sell
-75,124
Closed -$8.73M – 952
2023
Q1 		$8.73M Sell
75,124
-23,059
-23% -$2.58M 0.14% 181
2022
Q4 		$11.1M Buy
98,183
+23,683
+32% +$2.6M 0.19% 132
2022
Q3 		$6M Sell
74,500
-6,133
-8% -$519K 0.11% 229
2022
Q2 		$6.01M Buy
80,633
+3,313
+4% +$302K 0.1% 244
2022
Q1 		$9.89M Buy
77,320
+30,736
+66% +$3.36M 0.11% 188
2021
Q4 		$6.25M Buy
46,584
+44,640
+2,296% +$6.41M 0.06% 220
2021
Q3 		$266K Sell
1,944
-11,724
-86% -$1.48M ﹤0.01% 890
2021
Q2 		$1.46M Buy
+13,668
New +$1.31M 0.02% 440
2020
Q4 		– Sell
-39,300
Closed -$4.05M – 521
2020
Q3 		$4.05M Buy
+39,300
New +$4.11M 0.08% 95
2018
Q4 		– Sell
-323,072
Closed -$11.6M – 370
2018
Q3 		$11.6M Buy
+323,072
New +$10M 0.73% 37
2018
Q2 		– Sell
-379,472
Closed -$5.44M – 510
2018
Q1 		$5.44M Hold
379,472
– – 0.56% 28
2017
Q4 		$5.44M Buy
+379,472
New +$4.93M 0.56% 28
2016
Q4 		– Sell
-314,928
Closed -$6.9M – 342
2016
Q3 		$6.9M Buy
+314,928
New +$7.01M 0.66% 31
2015
Q4 		– Sell
-296,572
Closed -$6.37M – 262
2015
Q3 		$6.37M Buy
296,572
+275,116
+1,282% +$6.14M 0.7% 33
2015
Q2 		$429K Buy
+21,456
New +$377K 0.05% 322

Other funds holding DXCM

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

LMR Partners's DXCM Position: Q2 2026 in Review

LMR Partners reduced its DexCom (DXCM) stake by 99% in Q2 2026, selling an estimated $20.4M and leaving 3,232 shares worth $218K. The position accounts for ﹤0.01% of the portfolio, ranked #1312.

LMR Partners first reported a position in DXCM in Q2 2015 and has held it in 21 quarters since. The position peaked at $19.4M in Q1 2026. 973 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.

  • LMR Partners held 3,232 shares of DexCom worth $218K as of Q2 2026.
  • LMR Partners sold 305,854 DexCom shares in Q2 2026, an estimated $20.4M.
  • DexCom made up ﹤0.01% of LMR Partners's portfolio in Q2 2026, its #1312 holding.
  • LMR Partners first reported a position in DexCom in Q2 2015 and has held it in 21 quarters since.
  • LMR Partners's DexCom position peaked at $19.4M in Q1 2026.
  • 973 funds tracked by Wall St. Rank held DexCom as of Q2 2026.

Based on LMR Partners's 13F filing for Q2 2026, filed 14 Aug 2026.